pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

egenesis PRESS RELEASE ARCHIVE

Jun 13, 2023

eGenesis Announces Publication in Nature Communications Characterizing Renal Physiology and Endocrine Function in Non-Human Primates Post Xenograft Transplant

Jun 5, 2023

eGenesis Presents New Data on Long-Term Survival in Preclinical Kidney Xenotransplantation at American Transplant Congress 2023

Jan 24, 2023

eGenesis Announces Knut Niss as Chief Technology Officer

Jan 9, 2023

eGenesis and Eledon Pharmaceuticals Announce Collaboration for Use of Tegoprubart in Preclinical Xenotransplantation Studies

Apr 19, 2022

eGenesis Promotes Michael Curtis, Ph.D., to Chief Executive Officer

Apr 4, 2022

eGenesis Appoints Eliezer Katz, M.D., FACS, as Chief Medical Officer

Mar 9, 2022

eGenesis Announces Research Collaboration with the University of Miami to Evaluate Human Compatible Islet Cells in Diabetes Model

Jun 9, 2021

eGenesis Appoints Bradford Smith as an Independent Member of Its Board of Directors

Apr 1, 2021

eGenesis Expands Research Collaboration with Leading Academic Medical Center

Mar 4, 2021

eGenesis Appoints Veteran Financial Executive, Sapna Srivastava, Ph.D., as Chief Financial Officer

Mar 2, 2021

eGenesis Announces $125 Million Series C Financing

Nov 5, 2020

eGenesis Announces Research Collaboration with Leading Academic Medical Center

Sep 1, 2020

eGenesis Appoints Veteran Biotechnology Development Executive, Michael Curtis, Ph.D., as President of Research and Development

Jul 1, 2020

eGenesis Appoints Accomplished Biopharmaceutical Executive, Peter Hanson, DVM, Ph.D., as Chief Operating Officer

Jun 2, 2020

eGenesis Expands Research Collaboration with Massachusetts General Hospital

Jun 2, 2020

eGenesis Expands Research Collaboration with Massachusetts General Hospital

May 20, 2020

eGenesis Strengthens Production Capabilities with Acquisition of ICBiotec

May 20, 2020

eGenesis Strengthens Production Capabilities with Acquisition of ICBiotec

May 20, 2020

eGenesis Appoints Veteran Financial Executive, Sapna Srivastava, Ph.D., as Chief Financial Officer

Apr 6, 2020

eGenesis Appoints David A. Carmel as Senior Vice President, Public Affairs and Communications

Nov 7, 2019

Bayer invests $50 Million in eGenesis Series B financing round

Nov 7, 2019

eGenesis Announces $100 Million Series B Financing

Jun 11, 2019

eGenesis Appoints Ariel Jasie as Chief Business Officer and General Counsel

Jan 17, 2019

eGenesis Appoints Industry Veteran Paul Sekhri as President and Chief Executive Officer

Mar 16, 2017

eGenesis Announces $38 Million Series A Financing, Led by Biomatics Capital and ARCH Venture Partners, to Solve Shortage of Organs for Donation

Google Analytics Alternative